BIO-RAD LABORATORIES, INC. — Director's Dealing 2022

Dec 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2022-12-16

Reporting Person: WRIGHT DARA (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-16	Bio-Rad A Common Stock	M	502	$.00	Acquired	1987.9146	Direct
2022-12-16	Bio-Rad A Common Stock	F	226	$407.98	Disposed	1761.9146	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-16	Restricted Stock Units	$0	M	502	Disposed		Bio-Rad A Common Stock (502)	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Includes 26.0150 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: On December 16, 2019, the reporting person was granted 2,511 restricted stock units, vesting in 5 equal annual installments beginning on the first anniversary of the grant date.